You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

contiguous stage II marginal zone lymphoma

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Sedentary Behavior Trial in Phoenix (Stand & Move at Work, Stand & Move at Work+)

Not yet recruiting
  • Sedentary Behavior
  • Stand & Move at Work
  • Stand & Move at Work+
  • Phoenix, Arizona
    Arizona State University College of Health Solutions
Jul 29, 2022

Adult T-Cell Lymphoma/Leukemia, Sezary Syndrome, Mycosis Fungoides Trial run by the NCI (Recombinant human Interleukin-15

Completed
Has Results
  • Adult T-Cell Lymphoma/Leukemia
  • +2 more
  • Recombinant human Interleukin-15 (rhIL-15)
  • Mogamulizumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 9, 2022

Advanced Malignant Tumor, ATM Gene Mutation, BRCA1 Gene Mutation Trial in Houston (Laboratory Biomarker Analysis,

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2022

Huntington Disease Trial in United States (intra-striatal rAAV5-miHTT, Imitation (sham) surgery)

Recruiting
  • Huntington Disease
  • intra-striatal rAAV5-miHTT
  • Imitation (sham) surgery
  • Birmingham, Alabama
  • +11 more
Dec 2, 2021

Chronic Non-malignant Pain, Chronic Pain, Pain, Back Trial in United States (Medtronic SynchroMed™ II infusion system,

Completed
  • Chronic Non-malignant Pain
  • +3 more
  • Medtronic SynchroMed™ II infusion system
  • Preservative-free morphine sulfate (PFMS)
  • Anchorage, Alaska
  • +15 more
Dec 9, 2021

Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)

Not yet recruiting
  • Locally Advanced Unresectable Gastric Cancer
  • Guangzhou, Guangdong, China
    Cancer center of SunYat-sen University
Aug 11, 2023

Subclinical Hypothyroidism and Normogonadotropic Anovulation

Recruiting
  • Euthyroid, Aged 18-45, Ovulation Disorders
  • Comparison of laboratory test results in women in the 4 study arms
  • Krakow, Poland
    Jagiellonian University Medical College, Department of Gynecolog
Mar 11, 2023

Parkinson Disease Trial in Ghent (Baseline assessment of demographic, anthropometric and clinical characteristics, Locomotor

Active, not recruiting
  • Parkinson Disease
  • Baseline assessment of demographic, anthropometric and clinical characteristics
  • +3 more
  • Ghent, Belgium
  • +1 more
Oct 20, 2021

Cardiovascular Diseases, End Stage Renal Disease Trial (Dapagliflozin, Placebo)

Withdrawn
  • Cardiovascular Diseases
  • End Stage Renal Disease
  • (no location specified)
Oct 13, 2021

Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)

Completed
Has Results
  • Neuroblastoma
  • anti-GD2 murine IgG3 monoclonal antibody 3F8
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Apr 21, 2022

Pelvic Organ Prolapse Trial in Beijing (Extraperitoneal high sacral ligament suspension surgery, Sacrospinous ligament fixation)

Recruiting
  • Pelvic Organ Prolapse
  • Extraperitoneal high sacral ligament suspension surgery
  • Sacrospinous ligament fixation
  • Beijing, Beijing, China
    Peking University People's Hospital
Jan 8, 2022

Skin Angiosarcoma, Skin Radiation-Related Angiosarcoma, Visceral Angiosarcoma Trial in Guam, United States (drug, biological,

Active, not recruiting
  • Skin Angiosarcoma
  • +2 more
  • Cabozantinib S-malate
  • +4 more
  • Phoenix, Arizona
  • +171 more
Dec 28, 2022

Part 1:r/r B-cell Malignancies, Part 2:B-cell Malignancies Trial in United States (Orelabrutinib (ICP-022))

Recruiting
  • Part 1：r/r B-cell Malignancies
  • Part 2：B-cell Malignancies
  • Orelabrutinib (ICP-022)
  • Phoenix, Arizona
  • +26 more
Dec 7, 2021

Leukemia, Lymphoblastic, Acute, Pediatric Trial in United States (clofarabine (IV formulation))

Completed
  • Leukemia, Lymphoblastic, Acute, Pediatric
  • clofarabine (IV formulation)
  • Los Angeles, California
  • +13 more
May 26, 2022

Transposition of Great Vessels, Tetralogy of Fallot, Truncus Arteriosus Trial (Percutaneous intervention (stent) for PA

Not yet recruiting
  • Transposition of Great Vessels
  • +6 more
  • Percutaneous intervention (stent) for PA stenosis
  • (no location specified)
Mar 29, 2023

Uterine Cervical Cancer Trial in Beijing (SG001)

Recruiting
  • Uterine Cervical Cancer
  • Beijing, China
    National Cancer Center/Cancer Hospital,Chinese Academy of Medica
Nov 14, 2021

Locally Advanced Head and Neck Squamous Cell Carcinoma, Neoadjuvant Therapy Trial in Zhuhai (PD-1 inhibitor+ Gemcitabine +

Recruiting
  • Locally Advanced Head and Neck Squamous Cell Carcinoma
  • Neoadjuvant Therapy
  • PD-1 inhibitor+ Gemcitabine + Cisplatin
  • Zhuhai, Guangdong, China
    Fifth Affilliated Hospital of Sun Yat-sen University
Jun 23, 2021

Renal Pelvis and Ureter Urothelial Carcinoma Trial in Los Angeles (procedure, drug, biological)

Not yet recruiting
  • Renal Pelvis and Ureter Urothelial Carcinoma
  • Biopsy
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Mar 15, 2023

Lymphoma, Follicular, Lymphoma, Low-Grade, Lymphoma, Intermediate-Grade Trial in Munich (procedure, drug, other)

Active, not recruiting
  • Lymphoma, Follicular
  • +2 more
  • FCM
  • +3 more
  • Munich, Germany
    German Low Grade Study Group (Glsg)
May 6, 2021

Activation Patterns in Colorectal Cancer

Unknown status
  • Colorectal Surgery for Stage II / III Primary Colorectal Cancer
  • Assess the difference in MOR-1 expression between healthy and tumor tissue
  • (no location specified)
May 17, 2020

Agitation, Emergence Trial in Amman (Ketamine Hydrochloride)

Recruiting
  • Agitation, Emergence
  • Ketamine Hydrochloride
  • Amman, Jordan
    Jordanian Royal Medical Services
May 26, 2022

Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic Lymphoma Trial in China

Completed
Has Results
  • Relapsed or Refractory Chronic Lymphocytic Leukemia
  • Relapsed or Refractory Small Lymphocytic Lymphoma
  • Beijing, Beijing, China
  • +15 more
Sep 29, 2021

Autism Spectrum Disorder Trial in Paris (Lithium Carbonate, Placebo)

Recruiting
  • Autism Spectrum Disorder
  • Lithium Carbonate
  • Placebo
  • Paris, France
    Hôpital Robert Debré
Sep 15, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

LDL-Apheresis for FSGS CardioRenal Outcomes

Enrolling by invitation
  • Focal Segmental Glomerulosclerosis
  • No intervention
  • Cincinnati, Ohio
  • +1 more
Jan 25, 2023